Clinical Trial Update: A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating the combination of VS-6766 and cetuximab in patients with advanced colorectal cancer. Recruitment is active at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• VS-6766 (VS-6766)

Snippet

Sponsor: University of Chicago | Conditions: Colorectal Cancer, Colorectal Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING